Literature DB >> 747188

Characterization of unusual hexosaminidase A (HEX A) deficient human mutants.

J S O'Brien, L Tennant, M L Veath, C R Scott, W E Bucknall.   

Abstract

Two families with unusual hexosaminidase A (HEX A) mutations are described. In one, the proband had the Tay-Sachs disease phenotype with considerable HEX A activity. In the second, the proband was phenotypically normal with absent HEX A activity. Activities using ganglioside GM2 as substrate demonstrate markedly reduced activities in the first case and half-normal activities in the second. Pedigree analyses indicate the presence of two different mutations. In the first, the proband appears to be an allelic compound HEX A 2-4 where mutation HEX A 4 leads to a diminution of HEX A activity against GM2 but not for the synthetic substrate, 4MU-beta-D-N-acetyl-glucosaminide, with HEX A 2 being the Tay-Sachs disease (or similar) mutation. In the second family, the proband is an allelic compound HEX A 2-5 where mutation HEX A 5 leads to a diminution of HEX A activity against the synthetic substrate, 4MU-beta-D-N-acetyl-glucosaminide, but not for GM2. The presence of either mutation will lead to false-negative (HEX A 4) or false-positive (HEX A 5) assignments of heterozygosity or homozygosity for GM2 gangliosidosis when synthetic substrates are employed. In both families, DM2 N-acetyl-beta-D-galactosaminidase activity in fibroblasts was an accurate determinant of phenotype.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 747188      PMCID: PMC1685872     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Studies on the substrate specificity of hexosaminidase A and B from liver.

Authors:  D A Wenger; S Okada; J S O'Brien
Journal:  Arch Biochem Biophys       Date:  1972-11       Impact factor: 4.013

3.  I-cell disease: biochemical studies.

Authors:  J G Leroy; M W Ho; M C MacBrinn; K Zielke; J Jacob; J S O'Brien
Journal:  Pediatr Res       Date:  1972-10       Impact factor: 3.756

4.  Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases.

Authors:  L G Tomasi; D K Fukushima; E H Kolodny
Journal:  Neurology       Date:  1974-12       Impact factor: 9.910

5.  Absence of -N-acetyl-D-hexosaminidase A activity in a healthy woman.

Authors:  J Vidgoff; N R Buist; J S O'Brien
Journal:  Am J Hum Genet       Date:  1973-07       Impact factor: 11.025

6.  Differential assay of human hexosaminidases A and B.

Authors:  N Dance; R G Price; D Robinson
Journal:  Biochim Biophys Acta       Date:  1970-12-29

7.  Suggestions for a nomenclature for the GM2 gangliosidoses making certain (possibly unwarrantable) assumptions.

Authors:  J S O'Brien
Journal:  Am J Hum Genet       Date:  1978-11       Impact factor: 11.025

8.  Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay.

Authors:  J S O'Brien; S Okada; A Chen; D L Fillerup
Journal:  N Engl J Med       Date:  1970-07-02       Impact factor: 91.245

9.  Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.

Authors:  J S O'Brien; G W Norden; A L Miller; R G Frost; T E Kelly
Journal:  Clin Genet       Date:  1977-03       Impact factor: 4.438

10.  N-acetyl-beta-hexosaminidase: role in the degradation of glycosaminoglycans.

Authors:  J N Thompson; A C Stoolmiller; R Matalon; A Dorfman
Journal:  Science       Date:  1973-08-31       Impact factor: 47.728

View more
  13 in total

Review 1.  "Pseudodeficiencies" of lysosomal hydrolases.

Authors:  G H Thomas
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

2.  Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.

Authors:  E Conzelmann; H J Kytzia; R Navon; K Sandhoff
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

3.  A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.

Authors:  B L Triggs-Raine; E H Mules; M M Kaback; J S Lim-Steele; C E Dowling; B R Akerman; M R Natowicz; E E Grebner; R Navon; J P Welch
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

4.  Two abnormalities of hexosaminidase A in clinically normal individuals.

Authors:  E E Grebner; D A Mansfield; S S Raghavan; E H Kolodny; A d'Azzo; E F Neufeld; L G Jackson
Journal:  Am J Hum Genet       Date:  1986-04       Impact factor: 11.025

5.  GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.

Authors:  S S Raghavan; A Krusell; J Krusell; T A Lyerla; E H Kolodny
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

6.  Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.

Authors:  P Hechtman; Z Kachra
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

7.  Normal adult with absent HEX A: immunoreactive HEX A is present.

Authors:  J S O'Brien; B Geiger
Journal:  Am J Hum Genet       Date:  1979-09       Impact factor: 11.025

8.  Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.

Authors:  B H Paw; M M Kaback; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Estimation of the frequency of hexosaminidase a variant alleles in the American Jewish population.

Authors:  D A Greenberg; M M Kaback
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

10.  Human neutral alpha-glucosidase C: genetic polymorphism including a "null" allele.

Authors:  F Martiniuk; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.